SkyQuest projects that the global personalized medicines market size will reach a value of USD 1352.81 Billion by 2031 , with a CAGR of 11.40% during the forecast period (2024-2031). The personalized ...

Thus far, her agency has worked on one successful identification with Othram.

Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK Biobank to create the world’s first ...

According to the latest study from Research,“ European Life Science Tools and Reagents Market, ” the market for COVID-19 diagnostics products was $14.7 billion in 2023 and expected to grow from $13.0 ...

Investors are likely keeping a close eye on the company’s continued investment in its pipeline and the potential positive impact these advances could have on its stock price in the future. Exact ...

Leveraging Big Data to Enhance AI in Cancer Detection and Treatment Integrating AI into the healthcare decision making process is helping to revolutionize the field and lead to more accurate and ...

Researchers at Children's Hospital of Philadelphia (CHOP) announced the creation of a new AI technology called CelloType, a ...

a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease ...

We speak to Morghan Lucas (MGZ, Munich) about emerging omics, cancer diagnostics her experience at the Festival of Genomics ...